Login / Signup

Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective.

Mercedeh GhadessiJunrui DiChenkun WangKiichiro ToyoizumiNan ShaoChaoqun MeiCharmaine DemanueleRui Sammi TangGianna McMillanRobert A Beckman
Published in: Orphanet journal of rare diseases (2023)
This paper discusses the planning and conduct of DCTs, which can increase the quality of trials with a specific focus on rare diseases.
Keyphrases
  • clinical trial
  • healthcare
  • health information
  • randomized controlled trial
  • emergency department
  • phase ii
  • social media
  • adverse drug
  • phase iii